Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	kinase binding	PSG4 PSG7 CEACAM3 SLC2A14 XBP1 ACVR1 CIT SLC2A3 CCNY CD8A NBEAL2 TRIM8 PXN PKP2 PSG8 MAPK8IP2	1.64e-05	969	97	16	GO:0019900
GeneOntologyMolecularFunction	xylose binding	SLC2A14 SLC2A3	2.34e-05	2	97	2	GO:0033222
GeneOntologyMolecularFunction	protein kinase binding	PSG4 PSG7 CEACAM3 XBP1 ACVR1 CIT CCNY CD8A NBEAL2 TRIM8 PXN PKP2 PSG8 MAPK8IP2	8.03e-05	873	97	14	GO:0019901
GeneOntologyMolecularFunction	2'-5'-oligoadenylate synthetase activity	OAS2 OASL	2.31e-04	5	97	2	GO:0001730
GeneOntologyMolecularFunction	metalloendopeptidase activity	CLCA4 TRABD2B MMP27 ADAM8 ADAMTS15	2.99e-04	120	97	5	GO:0004222
GeneOntologyMolecularFunction	galactose transmembrane transporter activity	SLC2A14 SLC2A3	3.46e-04	6	97	2	GO:0005354
GeneOntologyMolecularFunction	dehydroascorbic acid transmembrane transporter activity	SLC2A14 SLC2A3	6.42e-04	8	97	2	GO:0033300
GeneOntologyMolecularFunction	protein tyrosine kinase binding	PSG4 PSG7 CEACAM3 ACVR1 PSG8	8.03e-04	149	97	5	GO:1990782
GeneOntologyMolecularFunction	galactoside binding	SLC2A14 SLC2A3	8.22e-04	9	97	2	GO:0016936
GeneOntologyCellularComponent	acrosomal vesicle	ATP8B3 SPATA31A3 SPATA31A7 SLC2A14 SPATA31A6 SPATA31C1 SPATA31A5 SLC2A3 CFAP65 SPATA31A1	5.05e-08	206	99	10	GO:0001669
GeneOntologyCellularComponent	secretory vesicle	ATP8B3 SPATA31A3 STXBP5L SPATA31A7 CEACAM3 SLC2A14 ADAM8 SPATA31A6 SPATA31C1 SPATA31A5 SLC2A3 SYCN CFAP65 MYOF SPATA31A1 NBEAL2 STON2 EXOC3L1	2.00e-05	1246	99	18	GO:0099503
GeneOntologyCellularComponent	secretory granule	ATP8B3 SPATA31A3 STXBP5L SPATA31A7 CEACAM3 SLC2A14 ADAM8 SPATA31A6 SPATA31C1 SPATA31A5 SLC2A3 SYCN CFAP65 SPATA31A1 NBEAL2 EXOC3L1	2.13e-05	1014	99	16	GO:0030141
GeneOntologyCellularComponent	acrosomal membrane	ATP8B3 SLC2A14 SLC2A3 CFAP65	3.09e-05	38	99	4	GO:0002080
GeneOntologyCellularComponent	secretory granule membrane	ATP8B3 CEACAM3 SLC2A14 ADAM8 SLC2A3 SYCN CFAP65 NBEAL2	1.71e-04	329	99	8	GO:0030667
GeneOntologyCellularComponent	plasma membrane raft	SLC2A14 SLC2A3 EHD2 MYOF CD8A	6.76e-04	147	99	5	GO:0044853
GeneOntologyCellularComponent	aggresome	SLC2A14 SLC2A3 STRADB	8.96e-04	40	99	3	GO:0016235
GeneOntologyCellularComponent	serine/threonine protein kinase complex	PSG4 ACVR1 CCNY STRADB PSG8	9.09e-04	157	99	5	GO:1902554
GeneOntologyCellularComponent	protein kinase complex	PSG4 ACVR1 CCNY STRADB PSG8	1.30e-03	170	99	5	GO:1902911
GeneOntologyCellularComponent	nuclear ubiquitin ligase complex	ANAPC15 BABAM2 CDC27	1.62e-03	49	99	3	GO:0000152
Domain	DUF4599	SPATA31A3 SPATA31A7 SPATA31C2 SPATA31A6 SPATA31C1 SPATA31A5	1.42e-11	12	96	6	PF15371
Domain	DUF4599	SPATA31A3 SPATA31A7 SPATA31C2 SPATA31A6 SPATA31C1 SPATA31A5	1.42e-11	12	96	6	IPR027970
Domain	V-set	PSG4 PSG7 SIGLEC8 CEACAM3 JAML SLAMF6 CD8A BTNL3 PSG8	4.46e-07	184	96	9	PF07686
Domain	Ig_V-set	PSG4 PSG7 SIGLEC8 CEACAM3 JAML SLAMF6 CD8A BTNL3 PSG8	8.61e-07	199	96	9	IPR013106
Domain	Glc_transpt_3	SLC2A14 SLC2A3	2.61e-05	2	96	2	IPR002945
Domain	IG	PSG4 PSG7 SIGLEC8 CEACAM3 JAML SLAMF6 CD8A BTNL3 CEACAM16 PSG8	6.10e-05	421	96	10	SM00409
Domain	Ig_sub	PSG4 PSG7 SIGLEC8 CEACAM3 JAML SLAMF6 CD8A BTNL3 CEACAM16 PSG8	6.10e-05	421	96	10	IPR003599
Domain	OAS1_C	OAS2 OASL	1.56e-04	4	96	2	PF10421
Domain	-	OAS2 OASL	1.56e-04	4	96	2	1.10.1410.20
Domain	25A_SYNTH_1	OAS2 OASL	1.56e-04	4	96	2	PS00832
Domain	25A_SYNTH_2	OAS2 OASL	1.56e-04	4	96	2	PS00833
Domain	2-5-oligoadenylate_synth_CS	OAS2 OASL	1.56e-04	4	96	2	IPR006117
Domain	25A_SYNTH_3	OAS2 OASL	1.56e-04	4	96	2	PS50152
Domain	2-5-oligoAdlate_synth_1_dom2/C	OAS2 OASL	1.56e-04	4	96	2	IPR018952
Domain	2-5A_synthase	OAS2 OASL	1.56e-04	4	96	2	IPR026774
Domain	IG_LIKE	PSG4 PSG7 SIGLEC8 CEACAM3 JAML SLAMF6 CD8A BTNL3 CEACAM16 PSG8	2.15e-04	491	96	10	PS50835
Domain	2-5-oligoadenylate_synth_N	OAS2 OASL	2.59e-04	5	96	2	IPR006116
Domain	Ig-like_dom	PSG4 PSG7 SIGLEC8 CEACAM3 JAML SLAMF6 CD8A BTNL3 CEACAM16 PSG8	2.61e-04	503	96	10	IPR007110
Domain	Tubby_C	PLSCR5 TULP2	3.87e-04	6	96	2	IPR000007
Domain	Tubby_C-like	PLSCR5 TULP2	3.87e-04	6	96	2	IPR025659
Domain	Ig_2	PSG4 PSG7 CEACAM16 PSG8	5.44e-04	73	96	4	PF13895
Domain	-	EPOR PSG4 PSG7 SIGLEC8 CEACAM3 JAML SLAMF6 CD8A BTNL3 CEACAM16 PSG8	5.92e-04	663	96	11	2.60.40.10
Domain	Ig-like_fold	EPOR PSG4 PSG7 SIGLEC8 CEACAM3 JAML SLAMF6 CD8A BTNL3 CEACAM16 PSG8	9.91e-04	706	96	11	IPR013783
Domain	CNH	CIT NRK	2.29e-03	14	96	2	SM00036
Domain	Sugar/inositol_transpt	SLC2A14 SLC2A3	2.29e-03	14	96	2	IPR003663
Domain	CNH	CIT NRK	2.63e-03	15	96	2	PF00780
Domain	CNH	CIT NRK	2.63e-03	15	96	2	PS50219
Domain	CNH_dom	CIT NRK	2.63e-03	15	96	2	IPR001180
Domain	SUGAR_TRANSPORT_2	SLC2A14 SLC2A3	3.38e-03	17	96	2	PS00217
Domain	LIM	LMO7 PRICKLE2 PXN	5.40e-03	69	96	3	PF00412
Domain	-	LMO7 PRICKLE2 PXN	5.62e-03	70	96	3	2.10.110.10
Domain	Znf_LIM	LMO7 PRICKLE2 PXN	5.84e-03	71	96	3	IPR001781
Domain	LIM_DOMAIN_1	LMO7 PRICKLE2 PXN	5.84e-03	71	96	3	PS00478
Domain	LIM_DOMAIN_2	LMO7 PRICKLE2 PXN	5.84e-03	71	96	3	PS50023
Domain	LIM	LMO7 PRICKLE2 PXN	5.84e-03	71	96	3	SM00132
Domain	SUGAR_TRANSPORT_1	SLC2A14 SLC2A3	6.70e-03	24	96	2	PS00216
Pubmed	The testis-specific VAD1.3/AEP1 interacts with β-actin and syntaxin 1 and directs peri-nuclear/Golgi expression with bipartite nucleus localization (BNL) sequence.	SPATA31A3 SPATA31A7 SPATA31A6 SPATA31C1 SPATA31A5 SPATA31A1	4.56e-16	6	99	6	20850414
Pubmed	Targeted disruption of the spermatid-specific gene Spata31 causes male infertility.	SPATA31A3 SPATA31A7 SPATA31A6 SPATA31C1 SPATA31A5 SPATA31A1	4.56e-16	6	99	6	25930072
Pubmed	Majority of cerebrospinal fluid-contacting neurons in the spinal cord of C57Bl/6N mice is present in ectopic position unlike in other studied experimental mice strains and mammalian species.	SPATA31A3 SPATA31A7 SPATA31A6 SPATA31C1 SPATA31A5 SPATA31A1	5.89e-11	24	99	6	32212159
Pubmed	Reprogramming- and pluripotency-associated membrane proteins in mouse stem cells revealed by label-free quantitative proteomics.	SLC2A14 SLC2A3	8.02e-06	2	99	2	23615220
Pubmed	Sex-Specific Life Course Changes in the Neuro-Metabolic Phenotype of Glut3 Null Heterozygous Mice: Ketogenic Diet Ameliorates Electroencephalographic Seizures and Improves Sociability.	SLC2A14 SLC2A3	8.02e-06	2	99	2	28324109
Pubmed	Expression of the brain-type glucose transporter is restricted to brain and neuronal cells in mice.	SLC2A14 SLC2A3	8.02e-06	2	99	2	1516757
Pubmed	Glucose Transporter 3 Potentiates Degranulation and Is Required for Platelet Activation.	SLC2A14 SLC2A3	8.02e-06	2	99	2	28663252
Pubmed	Differential upregulation of human 2'5'OAS genes on systemic sclerosis: Detection of increased basal levels of OASL and OAS2 genes through a qPCR based assay.	OAS2 OASL	8.02e-06	2	99	2	24328427
Pubmed	Neuronal glucose transporter isoform 3 deficient mice demonstrate features of autism spectrum disorders.	SLC2A14 SLC2A3	8.02e-06	2	99	2	19506559
Pubmed	Copy-Number Variation of the Glucose Transporter Gene SLC2A3 and Congenital Heart Defects in the 22q11.2 Deletion Syndrome.	SLC2A14 SLC2A3	8.02e-06	2	99	2	25892112
Pubmed	CD205+ polymorphonuclear myeloid-derived suppressor cells suppress antitumor immunity by overexpressing GLUT3.	SLC2A14 SLC2A3	8.02e-06	2	99	2	33368883
Pubmed	Neuronal functions, feeding behavior, and energy balance in Slc2a3+/- mice.	SLC2A14 SLC2A3	8.02e-06	2	99	2	18780771
Pubmed	Canine brain glucose transporter 3: gene sequence, phylogenetic comparisons and analysis of functional sites.	SLC2A14 SLC2A3	8.02e-06	2	99	2	8654954
Pubmed	The endocytic recycling protein EHD2 interacts with myoferlin to regulate myoblast fusion.	EHD2 MYOF	8.02e-06	2	99	2	18502764
Pubmed	Expression of mouse-GLUT3 and human-GLUT3 glucose transporter proteins in brain.	SLC2A14 SLC2A3	8.02e-06	2	99	2	1734877
Pubmed	Sevoflurane Induces Learning and Memory Impairment in Young Mice Through a Reduction in Neuronal Glucose Transporter 3.	SLC2A14 SLC2A3	8.02e-06	2	99	2	31884568
Pubmed	Adult glut3 homozygous null mice survive to demonstrate neural excitability and altered neurobehavioral responses reminiscent of neurodevelopmental disorders.	SLC2A14 SLC2A3	8.02e-06	2	99	2	33482226
Pubmed	Temporal and spatial distribution of murine placental and brain GLUT3-luciferase transgene as a readout of in vivo transcription.	SLC2A14 SLC2A3	8.02e-06	2	99	2	23193055
Pubmed	Gene expression of GLUT3 glucose transporter regulated by glucose in vivo in mouse brain and in vitro in neuronal cell cultures from rat embryos.	SLC2A14 SLC2A3	8.02e-06	2	99	2	8198523
Pubmed	Glucose Transporter 3 is Essential for the Survival of Breast Cancer Cells in the Brain.	SLC2A14 SLC2A3	8.02e-06	2	99	2	31817208
Pubmed	Brain glucose transporter (Glut3) haploinsufficiency does not impair mouse brain glucose uptake.	SLC2A14 SLC2A3	8.02e-06	2	99	2	21316350
Pubmed	Altered lactate metabolism in Huntington's disease is dependent on GLUT3 expression.	SLC2A14 SLC2A3	8.02e-06	2	99	2	29582588
Pubmed	Placental glucose and amino acid transport in calorie-restricted wild-type and Glut3 null heterozygous mice.	SLC2A14 SLC2A3	8.02e-06	2	99	2	22700768
Pubmed	Glucose transporter isoform-3-null heterozygous mutation causes sexually dimorphic adiposity with insulin resistance.	SLC2A14 SLC2A3	8.02e-06	2	99	2	18445753
Pubmed	Increased osteoclastogenesis in mice lacking the carcinoembryonic antigen-related cell adhesion molecule 1.	PSG4 CEACAM3 PSG8	9.93e-06	15	99	3	25490771
Pubmed	Gene organization of the pregnancy-specific glycoprotein region on human chromosome 19: assembly and analysis of a 700-kb cosmid contig spanning the region.	PSG4 PSG7 PSG8	1.48e-05	17	99	3	7851895
Pubmed	Novel interactive partners of neuroligin 3: new aspects for pathogenesis of autism.	PLB1 PSG4 EBPL CCAR2	1.75e-05	54	99	4	25464930
Pubmed	NFκB up-regulation of glucose transporter 3 is essential for hyperactive mammalian target of rapamycin-induced aerobic glycolysis and tumor growth.	SLC2A14 SLC2A3	2.40e-05	3	99	2	25578782
Pubmed	Calpain I Activation Causes GLUT3 Proteolysis and Downregulation of O-GlcNAcylation in Alzheimer's Disease Brain.	SLC2A14 SLC2A3	2.40e-05	3	99	2	29614685
Pubmed	XBP1-elicited environment by chemotherapy potentiates repopulation of tongue cancer cells by enhancing miR-22/lncRNA/KAT6B-dependent NF-κB signalling.	XBP1 KAT6B	2.40e-05	3	99	2	36639835
Pubmed	Glucose transporter GLUT3: ontogeny, targeting, and role in the mouse blastocyst.	SLC2A14 SLC2A3	2.40e-05	3	99	2	9108057
Pubmed	Expression of Desmoglein 2, Desmocollin 3 and Plakophilin 2 in Placenta and Bone Marrow-Derived Mesenchymal Stromal Cells.	DSC3 PKP2	2.40e-05	3	99	2	28154962
Pubmed	Significant reduction of the GLUT3 level, but not GLUT1 level, was observed in the brain tissues of several scrapie experimental animals and scrapie-infected cell lines.	SLC2A14 SLC2A3	2.40e-05	3	99	2	24243341
Pubmed	Glucose transporter expression in brain. cDNA sequence of mouse GLUT3, the brain facilitative glucose transporter isoform, and identification of sites of expression by in situ hybridization.	SLC2A14 SLC2A3	2.40e-05	3	99	2	1730609
Pubmed	Glucose transporter isoform-3 mutations cause early pregnancy loss and fetal growth restriction.	SLC2A14 SLC2A3	2.40e-05	3	99	2	17213475
Pubmed	Gestational changes of glucose transporter gene expression in the mouse placenta and decidua.	SLC2A14 SLC2A3	2.40e-05	3	99	2	8905482
Pubmed	Regular Exercise Enhances Cognitive Function and Intracephalic GLUT Expression in Alzheimer's Disease Model Mice.	SLC2A14 SLC2A3	2.40e-05	3	99	2	31561359
Pubmed	High NOV/CCN3 expression during high-fat diet pregnancy in mice affects GLUT3 expression and the mTOR pathway.	SLC2A14 SLC2A3	2.40e-05	3	99	2	33586490
Pubmed	Hyperglycemia reduces mitochondrial content and glucose transporter expression in mouse embryos developing in vitro.	SLC2A14 SLC2A3	2.40e-05	3	99	2	19550108
Pubmed	LPCAT1 Facilitates Keratinocyte Hyperproliferation and Skin Inflammation in Psoriasis by Regulating GLUT3.	SLC2A14 SLC2A3	2.40e-05	3	99	2	38246582
Pubmed	Placental glucose transporter expression is regulated by glucocorticoids.	SLC2A14 SLC2A3	2.40e-05	3	99	2	10199793
Pubmed	Glucose transporter proteins in brain.	SLC2A14 SLC2A3	2.40e-05	3	99	2	7926364
Pubmed	Recurrent moderate hypoglycemia accelerates the progression of Alzheimer's disease through impairment of the TRPC6/GLUT3 pathway.	SLC2A14 SLC2A3	2.40e-05	3	99	2	35077394
Pubmed	A muscle-specific protein 'myoferlin' modulates IL-6/STAT3 signaling by chaperoning activated STAT3 to nucleus.	EHD2 MYOF	2.40e-05	3	99	2	28745314
Pubmed	Molecular cloning of murine homologue dentatorubral-pallidoluysian atrophy (DRPLA) cDNA: strong conservation of a polymorphic CAG repeat in the murine gene.	SLC2A14 SLC2A3	2.40e-05	3	99	2	9070948
Pubmed	Vitamin C enters mouse T cells as dehydroascorbic acid in vitro and does not recapitulate in vivo vitamin C effects.	SLC2A14 SLC2A3	2.40e-05	3	99	2	19327547
Pubmed	Glucose Metabolism Is Required for Platelet Hyperactivation in a Murine Model of Type 1 Diabetes.	SLC2A14 SLC2A3	2.40e-05	3	99	2	30765335
Pubmed	Deletion of GLUT1 and GLUT3 Reveals Multiple Roles for Glucose Metabolism in Platelet and Megakaryocyte Function.	SLC2A14 SLC2A3	2.40e-05	3	99	2	28746873
Pubmed	Evidence for a family of human glucose transporter-like proteins. Sequence and gene localization of a protein expressed in fetal skeletal muscle and other tissues.	SLC2A14 SLC2A3	2.40e-05	3	99	2	3170580
Pubmed	Detailed comparative map of human chromosome 19q and related regions of the mouse genome.	PSG4 CEACAM3 RYR1 PSG8	4.13e-05	67	99	4	8812484
Pubmed	The finished DNA sequence of human chromosome 12.	OAS2 CIT OASL PXN	4.63e-05	69	99	4	16541075
Pubmed	Difference in allelic expression of genes probably associated with tumor progression in murine fibrosarcomas and cell lines.	SLC2A14 SLC2A3	4.79e-05	4	99	2	7961103
Pubmed	Cytoprotective effects of hesperetin and hesperidin against amyloid β-induced impairment of glucose transport through downregulation of neuronal autophagy.	SLC2A14 SLC2A3	4.79e-05	4	99	2	22383310
Pubmed	Creb1-Mecp2-(m)CpG complex transactivates postnatal murine neuronal glucose transporter isoform 3 expression.	SLC2A14 SLC2A3	4.79e-05	4	99	2	23493374
Pubmed	Gene structure of the murine 2'-5'-oligoadenylate synthetase family.	OAS2 OASL	4.79e-05	4	99	2	12222967
Pubmed	Analysis of glucose metabolism by 18F-FDG-PET imaging and glucose transporter expression in a mouse model of intracerebral hemorrhage.	SLC2A14 SLC2A3	4.79e-05	4	99	2	34035344
Pubmed	Changes in Expression of Follicular Glucose Transporters May Be Involved in Ovarian Function Impairment during Diabetic Hyperglycemia.	SLC2A14 SLC2A3	4.79e-05	4	99	2	31882430
Pubmed	Neonatal hypothyroidism affects testicular glucose homeostasis through increased oxidative stress in prepubertal mice: effects on GLUT3, GLUT8 and Cx43.	SLC2A14 SLC2A3	4.79e-05	4	99	2	28471544
Pubmed	A Nodal enhanced micropeptide NEMEP regulates glucose uptake during mesendoderm differentiation of embryonic stem cells.	SLC2A14 SLC2A3	4.79e-05	4	99	2	35810171
Pubmed	Glucose transporter expression and functional role of hexokinase in insulin biosynthesis in mouse beta TC3 cells.	SLC2A14 SLC2A3	4.79e-05	4	99	2	7653530
Pubmed	Glucose utilization and glucose transporter proteins GLUT-1 and GLUT-3 in brains of diabetic (db/db) mice.	SLC2A14 SLC2A3	4.79e-05	4	99	2	9124334
Pubmed	The pregnancy-specific glycoprotein family of the immunoglobulin superfamily: identification of new members and estimation of family size.	PSG7 PSG8	4.79e-05	4	99	2	1572651
Pubmed	Oxygen-regulated expression of GLUT-1, GLUT-3, and VEGF in the mouse blastocyst.	SLC2A14 SLC2A3	4.79e-05	4	99	2	15515055
Pubmed	Maternal hyperglycemia alters glucose transport and utilization in mouse preimplantation embryos.	SLC2A14 SLC2A3	4.79e-05	4	99	2	9688872
Pubmed	Developmental regulation of genes mediating murine brain glucose uptake.	SLC2A14 SLC2A3	4.79e-05	4	99	2	10070152
Pubmed	In vitro analysis of the glucose-transport system in GLUT4-null skeletal muscle.	SLC2A14 SLC2A3	4.79e-05	4	99	2	10455018
Pubmed	Glucose transporter 3 is a rab11-dependent trafficking cargo and its transport to the cell surface is reduced in neurons of CAG140 Huntington's disease mice.	SLC2A14 SLC2A3	4.79e-05	4	99	2	25526803
Pubmed	Trans-activators regulating neuronal glucose transporter isoform-3 gene expression in mammalian neurons.	SLC2A14 SLC2A3	4.79e-05	4	99	2	15054091
Pubmed	Hypoxia regulation of facilitated glucose transporter-1 and glucose transporter-3 in mouse chondrocytes mediated by HIF-1alpha.	SLC2A14 SLC2A3	4.79e-05	4	99	2	17983831
Pubmed	Prenatal Exposure to Sodium Arsenite Alters Placental Glucose 1, 3, and 4 Transporters in Balb/c Mice.	SLC2A14 SLC2A3	4.79e-05	4	99	2	26339590
Pubmed	Endotoxin-induced enhancement of glucose influx into murine peritoneal macrophages via GLUT1.	SLC2A14 SLC2A3	4.79e-05	4	99	2	8557327
Pubmed	GLUT3 promotes macrophage signaling and function via RAS-mediated endocytosis in atopic dermatitis and wound healing.	SLC2A14 SLC2A3	4.79e-05	4	99	2	37721853
Pubmed	Variability in the 2'-5'-oligoadenylate synthetase gene cluster is associated with human predisposition to tick-borne encephalitis virus-induced disease.	OAS2 OASL	4.79e-05	4	99	2	21050126
Pubmed	Glucose uptake, utilization, and signaling in GLUT2-null islets.	SLC2A14 SLC2A3	4.79e-05	4	99	2	10969832
Pubmed	Developing Brain Glucose Transporters, Serotonin, Serotonin Transporter, and Oxytocin Receptor Expression in Response to Early-Life Hypocaloric and Hypercaloric Dietary, and Air Pollutant Exposures.	SLC2A14 SLC2A3	4.79e-05	4	99	2	33774619
Pubmed	Immunohistochemical localization and quantification of glucose transporters in the mouse brain.	SLC2A14 SLC2A3	4.79e-05	4	99	2	11955709
Pubmed	Nutrient Transporter Gene Expression in the Early Conceptus-Implications From Two Mouse Models of Diabetic Pregnancy.	SLC2A14 SLC2A3 CPT1C	4.92e-05	25	99	3	35478964
Pubmed	A mouse knockout library for secreted and transmembrane proteins.	CLCA4 SIGLEC8 SLC2A14 MMP27 JAML SLC2A3 GLMP NBEAL2	5.27e-05	460	99	8	20562862
Pubmed	The oligoadenylate synthetase family: an ancient protein family with multiple antiviral activities.	OAS2 OASL	7.98e-05	5	99	2	21142819
Pubmed	Genomic structure of the mouse 2',5'-oligoadenylate synthetase gene family.	OAS2 OASL	7.98e-05	5	99	2	12396720
Pubmed	Organization of the mouse microfibril-associated glycoprotein-2 (MAGP-2) gene.	SLC2A14 SLC2A3	7.98e-05	5	99	2	10723723
Pubmed	Developmental expression and cellular localization of glucose transporter molecules during mouse preimplantation development.	SLC2A14 SLC2A3	7.98e-05	5	99	2	1638987
Pubmed	Adaptation of nutrient supply to fetal demand in the mouse involves interaction between the Igf2 gene and placental transporter systems.	SLC2A14 SLC2A3	7.98e-05	5	99	2	16365304
Pubmed	The glucose transporter family: structure, function and tissue-specific expression.	SLC2A14 SLC2A3	7.98e-05	5	99	2	8240230
Pubmed	Hypoxic adaptation engages the CBP/CREST-induced coactivator complex of Creb-HIF-1α in transactivating murine neuroblastic glucose transporter.	SLC2A14 SLC2A3	7.98e-05	5	99	2	23321477
Pubmed	Prenatal expression of the GLUT4 glucose transporter in the mouse.	SLC2A14 SLC2A3	7.98e-05	5	99	2	10965149
Pubmed	GLUT1 Expression in Tumor-Associated Neutrophils Promotes Lung Cancer Growth and Resistance to Radiotherapy.	SLC2A14 SLC2A3	7.98e-05	5	99	2	33753374
Pubmed	Identification of a murine TEF-1-related gene expressed after mitogenic stimulation of quiescent fibroblasts and during myogenic differentiation.	SLC2A14 SLC2A3	7.98e-05	5	99	2	8662936
Pubmed	Differential screening of a PCR-generated mouse embryo cDNA library: glucose transporters are differentially expressed in early postimplantation mouse embryos.	SLC2A14 SLC2A3	7.98e-05	5	99	2	1289053
Pubmed	Molecular identification and functional characterization of the vitamin C transporters expressed by Sertoli cells.	SLC2A14 SLC2A3	1.19e-04	6	99	2	18668520
Pubmed	Metabolic mode peculiar to Meckel's cartilage: immunohistochemical comparisons of hypoxia-inducible factor-1alpha and glucose transporters in developing endochondral bones in mice.	SLC2A14 SLC2A3	1.19e-04	6	99	2	18705802
Pubmed	A novel LPS-inducible C-type lectin is a transcriptional target of NF-IL6 in macrophages.	SLC2A14 SLC2A3	1.19e-04	6	99	2	10528209
Pubmed	Assignment of a novel protein tyrosine phosphatase gene (Hcph) to mouse chromosome 6.	SLC2A14 SLC2A3	1.19e-04	6	99	2	1427910
Pubmed	HIV-1 Tat activates neuronal ryanodine receptors with rapid induction of the unfolded protein response and mitochondrial hyperpolarization.	XBP1 RYR1	1.19e-04	6	99	2	19009018
Pubmed	p53 regulates glucose metabolism through an IKK-NF-kappaB pathway and inhibits cell transformation.	SLC2A14 SLC2A3	1.19e-04	6	99	2	18391940
Pubmed	Combined deletion of Glut1 and Glut3 impairs lung adenocarcinoma growth.	SLC2A14 SLC2A3	1.19e-04	6	99	2	32571479
Pubmed	Glucose uptake mediated by glucose transporter 1 is essential for early tooth morphogenesis and size determination of murine molars.	SLC2A14 SLC2A3	1.19e-04	6	99	2	22226978
Pubmed	Characterization of genes which exhibit reduced expression during the retinoic acid-induced differentiation of F9 teratocarcinoma cells: involvement of cyclin D3 in RA-mediated growth arrest.	SLC2A14 SLC2A3	1.67e-04	7	99	2	9806360
Pubmed	Identification of putative downstream genes of Oct-3, a pluripotent cell-specific transcription factor.	SLC2A14 SLC2A3	1.67e-04	7	99	2	9140067
Pubmed	Characterization of cDNA encoding novel pregnancy-specific glycoprotein variants.	PSG4 PSG7	1.67e-04	7	99	2	7794280
Cytoband	Ensembl 112 genes in cytogenetic band chr19q13	SHANK1 PSG4 PSG7 SIGLEC8 CEACAM3 RYR1 SYCN TULP2 EHD2 ZC3H4 CPT1C CEACAM16 PSG8	1.79e-06	1192	99	13	chr19q13
Cytoband	19q13.2	PSG4 PSG7 CEACAM3 SYCN PSG8	2.98e-05	164	99	5	19q13.2
Cytoband	10q24.3	TRIM8 ALDH18A1	6.87e-05	6	99	2	10q24.3
Cytoband	Ensembl 112 genes in cytogenetic band chr9q12	SPATA31A7 SPATA31A5	1.28e-04	8	99	2	chr9q12
Cytoband	2p23.2	PLB1 BABAM2	3.54e-04	13	99	2	2p23.2
Cytoband	12q24.2	OAS2 OASL	5.42e-04	16	99	2	12q24.2
Cytoband	9p13.1	SPATA31A3 SPATA31A1	1.23e-03	24	99	2	9p13.1
GeneFamily	Adenosine receptors\|V-set domain containing	PSG4 SIGLEC8 CEACAM3 JAML SLAMF6 CD8A BTNL3 CEACAM16 PSG8	2.30e-09	163	58	9	590
GeneFamily	CD molecules\|V-set domain containing\|Pregnancy specific glycoproteins	PSG4 PSG7 PSG8	5.08e-06	11	58	3	1315
GeneFamily	LIM domain containing	LMO7 PRICKLE2 PXN	8.97e-04	59	58	3	1218
GeneFamily	Anaphase promoting complex \|Tetratricopeptide repeat domain containing	ANAPC15 CDC27	8.98e-04	14	58	2	402
GeneFamily	CD molecules\|V-set domain containing\|Immunoglobulin like domain containing\|Carcinoembryonic antigen related cell adhesion molecule family	CEACAM3 CEACAM16	2.67e-03	24	58	2	906
Coexpression	CAO_BLOOD_FLUMIST_AGE_05_14YO_CORRELATED_WITH_H3N2_VN_TITER_7DY_POSITIVE	OAS2 RSAD2 OASL	3.94e-06	9	96	3	M41098
Coexpression	QUEREC_PBMC_YF_17D_VACCINE_AGE_18_45YO_7DY_UP	OAS2 MYOF RSAD2 OASL	2.45e-05	46	96	4	M41048
Coexpression	QUEREC_PBMC_YF_17D_VACCINE_AGE_18_45YO_3DY_UP	OAS2 MYOF RSAD2 OASL	2.45e-05	46	96	4	M41047
Coexpression	FARMER_BREAST_CANCER_CLUSTER_1	OAS2 RSAD2 CD8A OASL	2.91e-05	48	96	4	M15015
ToppCell	CV-Severe-1\|CV / Virus stimulation, Condition and Cluster	PDE4A XBP1 OAS2 SLC2A3 RSAD2 CD8A OASL	2.83e-07	198	98	7	fc0e885e370ffb780eada62bb2b52065c2f8b26b
ToppCell	CV-Healthy-1\|Healthy / Virus stimulation, Condition and Cluster	XBP1 OAS2 SLC2A3 RSAD2 CD8A OASL	4.24e-06	192	98	6	2a2052b44e8f679ef484f03ba4fb37b0ec841b88
ToppCell	367C-Myeloid-Dendritic-cDC1\|Dendritic / Donor, Lineage, Cell class and subclass (all cells)	NAAA JMJD1C CD8A NBEAL2 PXN CLNK	4.64e-06	195	98	6	fca958f73de450ef813444d3dc590353f1c55326
ToppCell	CV-Severe\|CV / Virus stimulation, Condition and Cluster	XBP1 OAS2 SLC2A3 RSAD2 CD8A OASL	4.78e-06	196	98	6	d0ddeaaa9ad0576e312a49bd3e68d12addccad3c
ToppCell	Smart-start-Cell-Wel_seq-Non-neoplastic-Myeloid-Mono-Mono_naive-E\|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	CEACAM3 ADAM8 JAML JMJD1C SLC2A3 PIK3CD	4.92e-06	197	98	6	d2b2eaa6f7294ff56b84a69c8727c7e0f9fd0466
ToppCell	distal-1-Hematologic-Myeloid_Dendritic_Type_2\|1 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	PLB1 NAAA ADAM8 JAML UPK3A CLNK	5.06e-06	198	98	6	5b27949ac3fc7eb34949f9f360d57e6ae82a2368
ToppCell	BAL-Severe-cDC_1\|Severe / Compartment, Disease Groups and Clusters	OAS2 JAML SLC2A3 MYOF RSAD2 OASL	5.21e-06	199	98	6	9f5750212b887f92761ade33fc6e108cd5275297
ToppCell	Lung_Parenchyma-Severe-Myeloid-cDC\|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09)	NAAA CEACAM3 ADAM8 JAML UPK3A CLNK	5.36e-06	200	98	6	9744d53915c8dc9d5e011cbbb0ac7db44c615ce7
ToppCell	Parenchyma_COVID-19-Immune-TX-DCs\|Parenchyma_COVID-19 / Sample group, Lineage and Cell type	NAAA CEACAM3 ADAM8 JAML UPK3A CLNK	5.36e-06	200	98	6	6237e4b46b196e1d1610b2edc60af4716a6fed25
ToppCell	Lung_Parenchyma-Severe-Myeloid-cDC-DCs-\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	NAAA CEACAM3 ADAM8 JAML UPK3A CLNK	5.36e-06	200	98	6	b52f7534a5ff504dccc002ebc30836a87e43c123
ToppCell	Lung_Parenchyma-Severe-Myeloid-cDC-DCs\|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09)	NAAA CEACAM3 ADAM8 JAML UPK3A CLNK	5.36e-06	200	98	6	cb0ba75be8fb2ec47474559911df80d085c4dbc8
ToppCell	PBMC-Severe-Myeloid-Classical_Monocyte-Classical_Monocyte-\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)	JAML EHD2 MYOF PRICKLE2 GPRIN2	1.32e-05	137	98	5	12caa8ed7cc9e7a0f78c14ad5efe2fc28c3ce9be
ToppCell	facs-Limb_Muscle-ForelimbandHindlimb-24m\|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CLCA4 DSC3 SYCN UPK3A ATOH1	1.97e-05	149	98	5	d259e9137109eeb2662022f0915ca463f5bebdfe
ToppCell	facs-Liver-Liver_non-hepato/SCs_st-18m-Myeloid-neutrophil\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	OAS2 ADAM8 JAML SLC2A3 RSAD2	2.04e-05	150	98	5	6e806a028c0519489151c181d9907e05289e27e0
ToppCell	Healthy_Control-Myeloid-Macrophages-FCN1_high\|Healthy_Control / Condition, Lineage, Cell class and cell subclass	ADAM8 MYOF RSAD2 TMEM132A UPK3A	2.39e-05	155	98	5	cd2ccb4632713b4def3a1064599b78207e2e44c0
ToppCell	droplet-Heart-4Chambers-21m-Hematologic-nan\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ADAM8 JAML RYR1 CD8A CLNK	2.46e-05	156	98	5	5d97755db872d51522f6412a93704f3c79a084cd
ToppCell	PND01-Immune-Immune_Myeloid-Megakaryocyte/Platelet-Megakaryocyte/Platelet\|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	EPOR CIT SLC2A3 STON2 SERPINB2	2.86e-05	161	98	5	52556b89808e551540f33a13f57417a6696c2438
ToppCell	PND01-Immune-Immune_Myeloid-Megakaryocyte/Platelet-Megakaryocyte/Platelet-Megakaryocyte/Platelet_mature\|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	EPOR CIT SLC2A3 STON2 SERPINB2	2.86e-05	161	98	5	54f156cf2bd5a6ba9a78ec4e3ee28b89998aec2e
ToppCell	PND01-Immune-Immune_Myeloid-Megakaryocyte/Platelet\|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	EPOR CIT SLC2A3 STON2 SERPINB2	2.86e-05	161	98	5	242891be849a4398fe8bea44875ae1ba57950944
ToppCell	Dendritic_Cells-SSc-ILD_02\|World / lung cells shred on cell class, cell subclass, sample id	NAAA ADAM8 JAML UPK3A CLNK	3.04e-05	163	98	5	5fff3932c1c259010e3add7a3b2301df2fa37df1
ToppCell	PND28-Immune-Immune_Myeloid-DC-cDC1\|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	NAAA JAML RYR1 NRK CLNK	3.13e-05	164	98	5	5638d95c7cc5e59c4a7bda30268a904a01861a5f
ToppCell	PCW_05-06-Hematologic_Myeloid-Hem_Myeloid_dendritic-im_conventional_dendritic_(19)\|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung	OAS2 ADAM8 JAML UPK3A CLNK	3.51e-05	168	98	5	907692c1f03d3c9889ba1bed5a4844e2c379db8e
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Immune-Myeloid-Granulocytic\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	DSC3 SIGLEC8 CEACAM3 JAML PIK3CD	3.61e-05	169	98	5	2e15a9317da4017757d184f7cc91bd66b072ac51
ToppCell	droplet-Lung-LUNG-1m-Myeloid-Myeloid_Dendritic_Type_2\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	NAAA JAML RYR1 NBEAL2 ALDH18A1	3.61e-05	169	98	5	46f0f0de9a0894c454f93032e7a7a800f47c8276
ToppCell	control-Myeloid-Monocyte-derived_Macrophage\|control / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls	PDE4A SLC2A14 ADAM8 SLC2A3 UPK3A	3.82e-05	171	98	5	e828b684744a4fdf6b63ec033c4f000b39ca0d51
ToppCell	droplet-Kidney-nan-21m-Lymphocytic-lymphocyte\|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	NAAA ADAM8 JAML RYR1 CLNK	3.82e-05	171	98	5	0385d5834ae16bbb0c6a68893fec60e4dd1e478d
ToppCell	droplet-Kidney-nan-21m-Lymphocytic-CD45\|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	NAAA ADAM8 JAML RYR1 CLNK	3.82e-05	171	98	5	a3e3fe0cbab21abb178c482f5951e576529f7e30
ToppCell	droplet-Liver-nan-3m-Myeloid-Kupffer_cell\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TRABD2B MMP27 TULP2 MYOF STON2	3.93e-05	172	98	5	f814b6134ad608015765399d54cc1e5e1873ed34
ToppCell	356C-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_6\|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells)	EPOR JAML CD8A ZC3H4 TRIM8	3.93e-05	172	98	5	a9e13aa36087170dadca421ba9de588e5a1cf715
ToppCell	PND03-Immune-Immune_Myeloid-Megakaryocyte/Platelet\|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	GABRG3 EPOR SLC2A3 STON2 SERPINB2	3.93e-05	172	98	5	e39ea2f4edbf36ebf9604fa6f9349081859c596c
ToppCell	PND03-Immune-Immune_Myeloid-Megakaryocyte/Platelet-Megakaryocyte/Platelet\|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	GABRG3 EPOR SLC2A3 STON2 SERPINB2	3.93e-05	172	98	5	875ea290840e835952623b905eb610f3c71456d2
ToppCell	droplet-Kidney-KIDNEY-30m-Lymphocytic-lymphocyte\|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	NAAA ADAM8 JAML RYR1 CLNK	3.93e-05	172	98	5	e680abead2da75e50774da02384eb2729c839c01
ToppCell	PND03-Immune-Immune_Myeloid-Megakaryocyte/Platelet-Megakaryocyte/Platelet-Megakaryocyte/Platelet_mature\|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	GABRG3 EPOR SLC2A3 STON2 SERPINB2	3.93e-05	172	98	5	bcc50bed47465daa953ba91f17d1ee4c947ab461
ToppCell	droplet-Lung-LUNG-30m-Myeloid-Myeloid_Dendritic_Type_2\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	NAAA ADAM8 JAML RYR1 CLNK	3.93e-05	172	98	5	a5344760b10ecdc0101f78b93b8fc0f8107068c5
ToppCell	NS-control-d_0-4-Myeloid-Monocyte-derived_Macrophage\|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)	PDE4A SLC2A14 ADAM8 SLC2A3 UPK3A	4.15e-05	174	98	5	758984730cd1c3ccf6866a3a8f03d6e002f3edb6
ToppCell	facs-Lung-3m-Hematologic-myeloid-myeloid_dendritic_cell-dendritic_type_2\|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	NAAA ADAM8 JAML RYR1 CLNK	4.15e-05	174	98	5	6688424fc4e40c3c4a89669a2bc79369a726f1e6
ToppCell	droplet-Lung-21m-Hematologic-myeloid-myeloid_dendritic_cell-dendritic_type_2\|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	NAAA ANAPC15 ADAM8 JAML RYR1	4.26e-05	175	98	5	4655d3daa95e8ffa7d5ee4180de06b2fec361bfb
ToppCell	Monocytes-IFN-activated_Monocytes\|Monocytes / Immune cells in Rheumatoid Arthritis Joint Synovial Tissues	OAS2 ADAM8 SLC2A3 RSAD2 OASL	4.38e-05	176	98	5	6a4b403ee3e4dc4f23fbd7a154011e41fd429a9e
ToppCell	kidney_cells-Hypertensive_with+without-CKD-Immune-Myeloid-Macrophage_Dendritic-Classical_Dendritic_Cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	PLB1 NAAA CEACAM3 UPK3A CLNK	4.38e-05	176	98	5	5f8c1f917fba49f3b1c0d88b946eca242b668fde
ToppCell	facs-Lung-EPCAM-18m-Myeloid-Myeloid_Dendritic_Type_2\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	NAAA ADAM8 JAML RYR1 CLNK	4.50e-05	177	98	5	3cb96d7d56c9ff90f1f8a6caaf49e580e2524c7d
ToppCell	facs-Lung-18m-Hematologic-myeloid-myeloid_dendritic_cell-dendritic_type_2\|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	NAAA ADAM8 JAML RYR1 CLNK	4.75e-05	179	98	5	b7a2429d07d7146b32b3552a5f2a2542105a71e0
ToppCell	E18.5-Immune-Immune_Myeloid-Megakaryocyte/Platelet\|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	EPOR SLC2A3 NBEAL2 STON2 SERPINB2	4.87e-05	180	98	5	ca2a35bfb67347e47f511589a3d0f763e6664634
ToppCell	AT1_cells-Donor_08\|World / lung cells shred on cell class, cell subclass, sample id	EHD2 DUOX1 LMO7 NBEAL2 GPRIN2	4.87e-05	180	98	5	2d52cb5f77dde0e3dccac1333d4ec67ec680fcb2
ToppCell	3'_v3-lymph-node_spleen-Myeloid_Dendritic-DC1\|lymph-node_spleen / Manually curated celltypes from each tissue	NAAA CEACAM3 STON2 UPK3A CLNK	4.87e-05	180	98	5	a7db1f00566c9acab8b239cbf2e053fb3f2f6a0d
ToppCell	E18.5-Immune-Immune_Myeloid-Megakaryocyte/Platelet-Megakaryocyte/Platelet-Megakaryocyte/Platelet_mature\|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	EPOR SLC2A3 NBEAL2 STON2 SERPINB2	4.87e-05	180	98	5	4e9e8cde2919610c4ac0025b1c9819808048bc1d
ToppCell	E18.5-Immune-Immune_Myeloid-Megakaryocyte/Platelet-Megakaryocyte/Platelet\|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	EPOR SLC2A3 NBEAL2 STON2 SERPINB2	4.87e-05	180	98	5	466381bf93c3da6a2a241daadb68e9aad2964eae
ToppCell	390C-Myeloid-Dendritic-cDC1\|390C / Donor, Lineage, Cell class and subclass (all cells)	PLB1 NAAA CEACAM3 PKP2 CLNK	5.00e-05	181	98	5	d1c69171600b2d2aec96fa86fa757b588c265f7c
ToppCell	wk_08-11-Hematologic-Myeloid-pre-pDC/DC5\|wk_08-11 / Celltypes from embryonic and fetal-stage human lung	OAS2 JAML PIK3CD UPK3A CLNK	5.13e-05	182	98	5	fec8a2d6d4099722b8e1bb41222108ed74268fcf
ToppCell	367C-Myeloid-Dendritic-cDC1\|367C / Donor, Lineage, Cell class and subclass (all cells)	NAAA CEACAM3 PKP2 UPK3A CLNK	5.13e-05	182	98	5	6f5228ac47f9ab46d165740cf2655b5ba217acbe
ToppCell	343B-Lymphocytic-CD4_T-cell-Treg_cell_4\|CD4_T-cell / Donor, Lineage, Cell class and subclass (all cells)	PDE4A RYR1 RPS6KC1 TRIM8 CLNK	5.27e-05	183	98	5	3cbe0175d05fd39bc430de1ef471ff2c5b56460e
ToppCell	facs-Lung-EPCAM-24m-Myeloid-Myeloid_Dendritic_Type_2\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	NAAA ADAM8 JAML RYR1 CLNK	5.27e-05	183	98	5	107cc756c45d6e92181659868d91188814dae66d
ToppCell	PCW_10-12-Hematologic_Myeloid-Hem_Myeloid_dendritic-im_conventional_dendritic_(19)\|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung	PLB1 ADAM8 JAML UPK3A CLNK	5.41e-05	184	98	5	315bb14e848d8e8e4533122047df6f9b89b89d99
ToppCell	facs-Lung-24m-Hematologic-myeloid-myeloid_dendritic_cell-dendritic_type_2\|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	NAAA ADAM8 JAML RYR1 CLNK	5.55e-05	185	98	5	ed7b26bdebfd0df2b4f5020a855a052d94ae7219
ToppCell	367C-Myeloid-Dendritic-cDC1\|Myeloid / Donor, Lineage, Cell class and subclass (all cells)	NAAA CEACAM3 NBEAL2 PKP2 CLNK	5.84e-05	187	98	5	3748203b62abf51b74dfcfc4f18b3ba831b63a96
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Distal_Convoluted_Tubule_Cell_Type_1\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	PSG4 TOP6BL MYOF NBEAL2 NRK	5.84e-05	187	98	5	f124d2c699b717b7c02a1a70493f515b83dc2f4c
ToppCell	(3)_DC_1\|World / Lung cell shreds - cell class (v4) and cell subclass (v4)	NAAA CEACAM3 PKP2 UPK3A CLNK	5.99e-05	188	98	5	ee616d14e060385ee55e4cd5b60218e9374c6065
ToppCell	Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_1-D088\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	NPC1 MYOF LMO7 NBEAL2 NRK	5.99e-05	188	98	5	43a3a59f92ad93509d4166bd025aed0b1b39a008
ToppCell	NS-critical-d_07-13-Epithelial-IRC-IFNG_responsive_cell\|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)	CLCA4 RSAD2 LMO7 OASL SERPINB2	5.99e-05	188	98	5	6ee2e7fa80f48e4a7f3321b0776a4f697469bc61
ToppCell	droplet-Tongue-nan-24m-Epithelial-suprabasal_differentiating\|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PLB1 NAAA DSC3 CA13 MYOF	5.99e-05	188	98	5	b40146ed0af022422e6526116e5897c676ed9d71
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	PSG4 TOP6BL MYOF NBEAL2 NRK	6.14e-05	189	98	5	e32172ad09e93f6ac6ea2b92145b2b73003f7970
ToppCell	IPF-Myeloid-cDC2\|World / Disease state, Lineage and Cell class	PDE4A NAAA ADAM8 JAML UPK3A	6.45e-05	191	98	5	9fda87fb6bc5b8b6c0214ec909ebbc9f3f65319b
ToppCell	IPF-Myeloid-cDC2\|IPF / Disease state, Lineage and Cell class	PDE4A NAAA ADAM8 JAML UPK3A	6.61e-05	192	98	5	fe1de692fec48cba4a9bbc6eaa257260e8b4e800
ToppCell	367C-Myeloid-Dendritic\|367C / Donor, Lineage, Cell class and subclass (all cells)	NAAA JAML PKP2 UPK3A CLNK	6.78e-05	193	98	5	365e831ae6ac67fb36d8d70ef139f4ae7e32c83f
ToppCell	Bronchial-NucSeq-Immune_Myeloid-Macrophage_other-Macro_CCL\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	ATP8B3 PDE4A SLC2A14 OASL INO80B	6.78e-05	193	98	5	21a117cceb562439ca3fe129aad8cac5f5728b1f
ToppCell	Parenchymal-10x3prime_v2-Immune_Lymphocytic-T-T_CD8-CD8\|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations	ADAM8 JAML SLAMF6 CD8A OASL	6.95e-05	194	98	5	c57cf3cc9fc1a682019090369fc1d3adbf37c371
ToppCell	moderate-Epithelial-IRC-IFNG_responsive_cell\|moderate / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls	XBP1 RSAD2 LMO7 OASL SERPINB2	7.12e-05	195	98	5	4ea79451b9c040650a74831b64a41d36b180ac0f
ToppCell	Transplant_Alveoli_and_parenchyma-Immune-Dendritic_cells\|Immune / Tissue, Lineage and Cell class of Lung Cells from 10X	NAAA ADAM8 JAML UPK3A CLNK	7.12e-05	195	98	5	c12c73861f53e28f6e357001eccc1300db06e816
ToppCell	PBMC-Severe-Myeloid-cDC-cDC-cDC_9\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)	OAS2 ADAM8 JAML RSAD2 UPK3A	7.12e-05	195	98	5	dd28c63b53f2a97e3fac127294a465870dc371b3
ToppCell	PBMC-Severe-Myeloid-cDC-cDC-cDC_9\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	OAS2 ADAM8 JAML RSAD2 UPK3A	7.12e-05	195	98	5	d6ff38535898f90be6719cd5152291f2f4f8a746
ToppCell	saliva-Mild-Moderate_progression_d12-25-Myeloid-Granulocytic-Neutrophil\|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k)	CEACAM3 ADAM8 JAML JMJD1C SLC2A3	7.29e-05	196	98	5	fe8d3f45a64323947c36b127355d5940eb56c0ca
ToppCell	Adult-Immune-monocyte-D122\|Adult / Lineage, Cell type, age group and donor	PLB1 NAAA JAML PIK3CD UPK3A	7.29e-05	196	98	5	16b0acb6157534938ca83d4e909471e33a7d3c52
ToppCell	Mild\|World / Disease group and Cell class	OAS2 JAML RSAD2 CD8A OASL	7.29e-05	196	98	5	5e4ed4a5a437cfa002b92775992a791e27aa4c27
ToppCell	Mild-CD8+_T_activated\|World / Disease group and Cell class	OAS2 JAML RSAD2 CD8A OASL	7.29e-05	196	98	5	79632190e44fcef9d7c11d9b9e37f2ebf0e6e255
ToppCell	Transplant_Alveoli_and_parenchyma-Immune-Dendritic_cells\|Transplant_Alveoli_and_parenchyma / Tissue, Lineage and Cell class of Lung Cells from 10X	PDE4A NAAA ADAM8 JAML UPK3A	7.29e-05	196	98	5	f278b144b8deaee0bf41682081b9fbb0b1e82b19
ToppCell	saliva-Mild-Moderate_progression_d12-25-Myeloid-Granulocytic\|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k)	CEACAM3 ADAM8 JAML JMJD1C SLC2A3	7.29e-05	196	98	5	526d037bb12d81f1c235c60ddc787fbad0bbad77
ToppCell	Tracheal-NucSeq-Immune_Lymphocytic-T-T_CD8-gdT\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	JAML SLC2A3 SLAMF6 CD8A CLNK	7.47e-05	197	98	5	b803c07072a7860497d07a3be358a28a24359cbf
ToppCell	NS-moderate-d_16-33-Epithelial-IRC-IFNG_responsive_cell\|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)	XBP1 RSAD2 LMO7 OASL SERPINB2	7.47e-05	197	98	5	8eda7d5a44b18c805c963235aea794e9223d1ac0
ToppCell	10x_3'_v2v3-Non-neoplastic-Myeloid-DC-cDC2-Z\|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	CEACAM3 ADAM8 JAML UPK3A CLNK	7.47e-05	197	98	5	4f7c10a636646dfc82a84026c1b5a36603367abe
ToppCell	CD8+_Memory_T_cell-CV-1\|CD8+_Memory_T_cell / cell class, Virus stimulation and cluster	XBP1 OAS2 RSAD2 CD8A OASL	7.47e-05	197	98	5	e59b47bccc781b2117196fe322efa87559c237c6
ToppCell	proximal-3-Hematologic-Myeloid_Dendritic_Type_2\|3 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	PLB1 PDE4A ADAM8 JAML UPK3A	7.65e-05	198	98	5	2e07e62ed230763a6859a8ce19429b5ca8b365a6
ToppCell	CV-Severe-1\|Severe / Virus stimulation, Condition and Cluster	XBP1 OAS2 RSAD2 CD8A OASL	7.65e-05	198	98	5	9b9ee0b0f6cc92e7be94869604c98f43d57ff8ff
ToppCell	3'-Broncho-tracheal-Immune_Myeloid-Myeloid_monocytic-classical_monocyte-Classical_monocytes\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	JAML JMJD1C SLC2A3 SERPINB2 UPK3A	7.65e-05	198	98	5	4b6767bd6fd4bd43eed18fd4a34c20923fa795da
ToppCell	proximal-Hematologic-Myeloid_Dendritic_Type_2\|proximal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	PLB1 PDE4A ADAM8 JAML UPK3A	7.65e-05	198	98	5	3b0143efc33486c1e340ca57981c83cf7e2cad29
ToppCell	distal-Hematologic-Myeloid_Dendritic_Type_2\|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	PLB1 NAAA ADAM8 JAML UPK3A	7.65e-05	198	98	5	f44eb16695ea52e3f99073f5976590069b1d9c5a
ToppCell	COVID-19_Severe-Neu_1\|COVID-19_Severe / 5 Neutrophil clusters in COVID-19 patients	ADAM8 JAML SLC2A3 RSAD2 OASL	7.65e-05	198	98	5	bbe639ea5a636c985e509fb0a133ae3b60afac5a
ToppCell	Parenchymal-NucSeq-Immune_Lymphocytic-T-T_CD4-CD4_TRM/EMRA\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	SLC2A14 TULP2 CPT1C OASL CLNK	7.65e-05	198	98	5	90863377ed36afc30bc1a068612ad1adc77af5a8
ToppCell	LPS_only-Hematopoietic_Myeloid-Dendritic_cells-mDC\|LPS_only / Treatment groups by lineage, cell group, cell type	PDE4A NAAA ADAM8 JAML OASL	7.65e-05	198	98	5	53c22e81e530d6fc272d4a45c8d1bf125feb254d
ToppCell	proximal-Hematologic-Myeloid_Dendritic_Type_2-3\|proximal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	PLB1 PDE4A ADAM8 JAML UPK3A	7.65e-05	198	98	5	f254287e13328a8f3b14bf4e44736041ad35593e
ToppCell	3'-Broncho-tracheal-Immune_Myeloid-Myeloid_monocytic-classical_monocyte\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	JAML JMJD1C SLC2A3 SERPINB2 UPK3A	7.65e-05	198	98	5	18daf83309813f914b17bd226ea8a9269a26b107
ToppCell	Tracheal-NucSeq-Immune_Lymphocytic-T-T_CD4-CD4\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	JAML SLC2A3 SLAMF6 CD8A PIK3CD	7.83e-05	199	98	5	bc93e5c36ab60b66fb633c954b05d4dc09a7f152
ToppCell	10x_5'_v1-Non-neoplastic-Lymphoid-CD4/CD8-CD4_INF-Z\|10x_5'_v1 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	OAS2 SLC2A3 RSAD2 OASL EXOC3L1	7.83e-05	199	98	5	d3f36ede2fade550ec8f21a0448e71e1ff579ee2
ToppCell	Tracheal-NucSeq-Immune_Lymphocytic-T-T_CD4-CD4_TRM/EMRA\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	JAML SLC2A3 SLAMF6 CD8A OASL	7.83e-05	199	98	5	868ff080f72b6274a84e3ae0ddee4a32ed96472a
ToppCell	Parenchymal-10x5prime-Immune_Myeloid-Dendritic_cell-DC_1\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	NAAA CEACAM3 PKP2 UPK3A CLNK	7.83e-05	199	98	5	26ea06960e8ea061a71756750b84489609f78162
ToppCell	Parenchymal-10x3prime_v2-Immune_Lymphocytic-T-T_CD8-gdT\|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations	ADAM8 SLAMF6 CD8A OASL CLNK	7.83e-05	199	98	5	a0f1e0d1aa175c2dcc5e744fff8b56ddda5293df
ToppCell	Smart-start-Cell-Wel_seq-Non-neoplastic-Myeloid-TAM-MG-TAM-MG_pro-infl_II\|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	SIGLEC8 RYR1 MYOF RSAD2 OASL	7.83e-05	199	98	5	e7faf7d0cb43cf93149c446e5f718f84fa85477c
ToppCell	COVID-19_Severe-Neu_1\|World / 5 Neutrophil clusters in COVID-19 patients	ADAM8 JAML SLC2A3 RSAD2 OASL	7.83e-05	199	98	5	e4d8bf016fd95a440e30014a75587e097e90cfad
ToppCell	PBMC_fresh-frozen-Severe-critical_progression_d03-09-Myeloid-Monocytic-Nonclassical_Monocyte\|Severe-critical_progression_d03-09 / Compartment, severity and other cell annotations on 10x 3' data (130k)	CEACAM3 OAS2 JAML MYOF OASL	8.02e-05	200	98	5	52f2a97af2d77dd068b19531dad1b3fba2601e90
ToppCell	Parenchymal-10x5prime-Immune_Myeloid-Dendritic_cell-DC_2\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	PLB1 NAAA ADAM8 JAML UPK3A	8.02e-05	200	98	5	f0e7c2f07a7065511bf0b6521ce2e74e04e48544
ToppCell	Biopsy_Control_(H.)-Immune-cDCs\|Biopsy_Control_(H.) / Sample group, Lineage and Cell type	NAAA ADAM8 JAML UPK3A CLNK	8.02e-05	200	98	5	cc6ba99a877a13c63dc1d6f81538065a7f29b8f6
ToppCell	Parenchymal-10x5prime-Immune_Myeloid-Dendritic_cell\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	NAAA ADAM8 JAML UPK3A CLNK	8.02e-05	200	98	5	1adebb306112bfc4926678de80f70d35dd57a586
Drug	Diphemanil methylsulfate [62-97-5]; Up 200; 10.2uM; MCF7; HT_HG-U133A	EPOR TOP6BL EHD2 MYOF LMF2 PIK3CD PXN	1.49e-05	196	92	7	1494_UP
Drug	Condelphine [7633-69-4]; Up 200; 8.8uM; MCF7; HT_HG-U133A	SHANK1 NAAA SIGLEC8 RYR1 OASL PXN GPRIN2	1.69e-05	200	92	7	3538_UP
Drug	AC1L1IPV	PSG4 PSG7 CEACAM3 PSG8	2.73e-05	43	92	4	CID000004683
Drug	sodium butyrate	CEACAM3 SLC2A14 OAS2 BABAM2 SLC2A3 NRK OASL KAT6B	7.74e-05	344	92	8	CID005222465
Drug	Rescinnamin [24815-24-5]; Up 200; 6.4uM; MCF7; HT_HG-U133A	SHANK1 EPOR OAS2 MYOF LMF2 PIK3CD	9.40e-05	181	92	6	2785_UP
Drug	ApApA(Sp)A	OAS2 OASL	9.64e-05	4	92	2	CID000501019
Drug	ApA(Sp)A	OAS2 OASL	9.64e-05	4	92	2	CID000501015
Drug	ApA(Sp)ApA	OAS2 OASL	9.64e-05	4	92	2	CID000501017
Drug	A(Sp)ApA	OAS2 OASL	9.64e-05	4	92	2	CID000501013
Drug	adenosine N'-oxide	OAS2 OASL	9.64e-05	4	92	2	CID000459896
Drug	poly(I,8-azidoI).poly(C	OAS2 OASL	9.64e-05	4	92	2	CID003081572
Drug	Fenoterol hydrobromide [1944-12-3]; Up 200; 10.4uM; PC3; HT_HG-U133A	SIGLEC8 OAS2 TULP2 LMO7 HEMK1 GPRIN2	9.69e-05	182	92	6	6331_UP
Drug	Mephentermine hemisulfate [1212-72-2]; Up 200; 9.4uM; MCF7; HT_HG-U133A	GABRG3 NAAA SIGLEC8 OAS2 SLC2A3 OASL	1.06e-04	185	92	6	4707_UP
Drug	Retinoic acid [302-79-4]; Up 200; 13.4uM; MCF7; HT_HG-U133A	OAS2 ADAM8 LMF2 OASL UPK3A INO80B	1.06e-04	185	92	6	6243_UP
Drug	Isoconazole [27523-40-6]; Up 200; 9.6uM; MCF7; HT_HG-U133A	ADAM8 BTNL3 LMO7 OASL PXN UPK3A	1.09e-04	186	92	6	2218_UP
Drug	Cyclosporin A [59865-13-3]; Up 200; 3.4uM; HL60; HT_HG-U133A	LDAF1 OAS2 SERPINB2 HEMK1 KAT6B INO80B	1.19e-04	189	92	6	1331_UP
Drug	Desipramine hydrochloride [58-28-6]; Up 200; 13.2uM; PC3; HT_HG-U133A	SIGLEC8 CEACAM3 OAS2 RYR1 OASL HEMK1	1.26e-04	191	92	6	6693_UP
Drug	Proguanil hydrochloride [637-32-1]; Down 200; 13.8uM; MCF7; HT_HG-U133A	EPOR NAAA TOP6BL BABAM2 MYOF INO80B	1.30e-04	192	92	6	3505_DN
Drug	Norethindrone [68-22-4]; Up 200; 13.4uM; PC3; HT_HG-U133A	SIGLEC8 OAS2 DUOX1 RSAD2 OASL SERPINB2	1.38e-04	194	92	6	5055_UP
Drug	ICI 182,780; Up 200; 0.01uM; MCF7; HT_HG-U133A	EPOR CEACAM3 ACVR1 EHD2 MYOF OASL	1.38e-04	194	92	6	6955_UP
Drug	Diethylstilbestrol [56-53-1]; Down 200; 15uM; PC3; HT_HG-U133A	STXBP5L ADAM8 MYOF LMF2 PXN HEMK1	1.41e-04	195	92	6	3812_DN
Drug	Bicuculline (+) [485-49-4]; Up 200; 10.8uM; MCF7; HT_HG-U133A	TOP6BL ADAM8 RYR1 LMF2 CD8A INO80B	1.41e-04	195	92	6	2796_UP
Drug	Homosalate [118-56-9]; Up 200; 15.2uM; MCF7; HT_HG-U133A	SLC2A3 RYR1 LMF2 LMO7 PIK3CD PXN	1.41e-04	195	92	6	4355_UP
Drug	Iressa; Up 200; 10uM; HL60; HG-U133A	EPOR NAAA LDAF1 OASL PXN KAT6B	1.41e-04	195	92	6	541_UP
Drug	Tocopherol (R,S) [10191-41-0]; Down 200; 9.2uM; MCF7; HT_HG-U133A	EPOR PDE4A BABAM2 GATAD1 HEMK1 KAT6B	1.41e-04	195	92	6	4961_DN
Drug	Doxycycline hydrochloride [10592-13-9]; Down 200; 8.4uM; HL60; HT_HG-U133A	EPOR PDE4A HEMK1 UPK3A KAT6B INO80B	1.45e-04	196	92	6	2737_DN
Drug	Bretylium tosylate [61-75-6]; Up 200; 9.6uM; MCF7; HT_HG-U133A	EPOR SIGLEC8 CEACAM3 OAS2 BABAM2 MYOF	1.45e-04	196	92	6	3394_UP
Drug	Benzylpenicillin sodium [69-57-8]; Up 200; 11.2uM; MCF7; HT_HG-U133A	DSC3 SIGLEC8 RYR1 MYOF OASL UPK3A	1.50e-04	197	92	6	3577_UP
Drug	Pyrantel tartrate [33401-94-4]; Down 200; 11.2uM; MCF7; HT_HG-U133A	LDAF1 ADAM8 LMF2 OASL CDC27 MAPK8IP2	1.50e-04	197	92	6	2260_DN
Drug	Doxepin hydrochloride [1229-29-4]; Up 200; 12.6uM; HL60; HT_HG-U133A	PDE4A SIGLEC8 MYOF LMF2 HEMK1 MAPK8IP2	1.50e-04	197	92	6	2384_UP
Drug	Salbutamol [18559-94-9]; Down 200; 16.8uM; MCF7; HT_HG-U133A	EPOR TOP6BL BABAM2 OASL PXN GPRIN2	1.50e-04	197	92	6	2306_DN
Drug	Pentylenetetrazole [54-95-5]; Up 200; 29uM; HL60; HG-U133A	EPOR LDAF1 CEACAM3 ADAM8 GPRIN2 RPAP2	1.50e-04	197	92	6	1408_UP
Drug	Cyclizine hydrochloride [303-25-3]; Up 200; 13.2uM; MCF7; HT_HG-U133A	OAS2 TOP6BL NBEAL2 PKP2 UPK3A MAPK8IP2	1.50e-04	197	92	6	2880_UP
Drug	Metanephrine hydrochloride DL [881-95-8]; Down 200; 17.2uM; MCF7; HT_HG-U133A	NAAA OAS2 LMF2 OASL PXN INO80B	1.50e-04	197	92	6	1515_DN
Drug	Isocorydine (+) [475-67-2]; Up 200; 11.8uM; MCF7; HT_HG-U133A	EPOR STXBP5L SLC2A3 RYR1 CD8A INO80B	1.54e-04	198	92	6	6843_UP
Drug	Chicago sky blue 6B [2610-05-1]; Down 200; 4uM; MCF7; HT_HG-U133A	EPOR BABAM2 HEMK1 CDC27 INO80B MAPK8IP2	1.54e-04	198	92	6	4971_DN
Drug	Propranolol hydrochloride [318-98-9]; Up 200; 13.6uM; MCF7; HT_HG-U133A	ADAM8 RYR1 TULP2 MYOF CD8A HEMK1	1.54e-04	198	92	6	3396_UP
Drug	Decamethonium bromide [541-22-0]; Up 200; 9.6uM; MCF7; HT_HG-U133A	EPOR MYOF LMF2 CD8A OASL PXN	1.54e-04	198	92	6	7353_UP
Drug	Alprostadil [745-65-3]; Up 200; 11.2uM; MCF7; HT_HG-U133A	GABRG3 PDE4A CEACAM3 OAS2 ADAM8 DUOX1	1.54e-04	198	92	6	4179_UP
Drug	Dicumarol [66-76-2]; Down 200; 11.8uM; MCF7; HT_HG-U133A	EPOR LDAF1 ADAM8 CIT NBEAL2 TMEM132A	1.54e-04	198	92	6	3423_DN
Drug	Phensuximide [86-34-0]; Up 200; 21.2uM; MCF7; HT_HG-U133A	GABRG3 DSC3 OAS2 SLC2A3 PXN INO80B	1.54e-04	198	92	6	3521_UP
Drug	(1)-Nipecotic acid [498-95-3]; Down 200; 31uM; MCF7; HT_HG-U133A	DSC3 MYOF PIK3CD PXN MAPK8IP2 GPRIN2	1.54e-04	198	92	6	6500_DN
Drug	Acemetacin [53164-05-9]; Down 200; 9.6uM; HL60; HT_HG-U133A	STXBP5L OAS2 ADAM8 SLC2A3 HEMK1 KAT6B	1.54e-04	198	92	6	2411_DN
Drug	Benzamil hydrochloride [2898-76-2]; Down 200; 11.2uM; PC3; HT_HG-U133A	NAAA MYOF TMEM132A OASL HEMK1 INO80B	1.58e-04	199	92	6	4294_DN
Drug	Delcorine; Down 200; 8.4uM; MCF7; HT_HG-U133A	DSC3 OAS2 MYOF LMF2 CD8A PXN	1.58e-04	199	92	6	6033_DN
Drug	rofecoxib; Up 200; 10uM; PC3; HG-U133A	MMP27 OAS2 BABAM2 CD8A OASL GPRIN2	1.62e-04	200	92	6	463_UP
Disease	cD177 antigen measurement	PSG4 PSG7 PSG8	1.96e-05	18	87	3	EFO_0021866
Disease	renal overload-type gout	SPATA31C2 SPATA31C1	1.28e-04	6	87	2	EFO_0021525
Disease	eosinophil cationic protein measurement	SPATA31C2 SPATA31C1	2.38e-04	8	87	2	EFO_0010913
Disease	longitudinal alcohol consumption measurement	SPATA31C2 SPATA31C1	3.05e-04	9	87	2	EFO_0007645
Disease	Bipolar I disorder	XBP1 KAT6B	4.65e-04	11	87	2	C0853193
Disease	Influenza	OAS2 RSAD2 OASL	4.93e-04	52	87	3	C0021400
Disease	C-C motif chemokine 28 measurement	JMJD1C SLC2A3	5.56e-04	12	87	2	EFO_0020199
Disease	cataract (biomarker_via_orthology)	SLC2A14 SLC2A3	6.56e-04	13	87	2	DOID:83 (biomarker_via_orthology)
Disease	egg allergy measurement, parental genotype effect measurement	SPATA31C2 SPATA31C1	6.56e-04	13	87	2	EFO_0005939, EFO_0007018
Disease	C-X-C motif chemokine 11 measurement	NAAA JMJD1C	7.64e-04	14	87	2	EFO_0008057
Disease	amygdala volume change measurement	SPATA31C2 SPATA31C1	1.00e-03	16	87	2	EFO_0021490
Disease	Infiltrating duct carcinoma of female breast	RPS6KC1 NRK	1.74e-03	21	87	2	C3165106
Disease	Bronchiectasis	RSPH4A PIK3CD	1.91e-03	22	87	2	C0006267

Protein segments in the cluster

Peptide	Gene	Start	Entry
LSWLSAFPLSQPFSL	CCAR2	261	Q8N163
LQPLFADLPSRQWLS	EXOC3L1	541	Q86VI1
ADLPSRQWLSSPELL	EXOC3L1	546	Q86VI1
SRSLFPPPTQAWLQT	PABPN1L	6	A6NDY0
TFFQPSPWRLASILL	BTNL3	226	Q6UXE8
PSLFPRVTETLWFNL	ANAPC15	6	P60006
SEPNRLLSQLPSGTW	CEACAM16	356	Q2WEN9
SFWSQPLLVPDNRRL	EHD2	256	Q9NZN4
NIPNRWFSDPTLTSL	ACVR1	456	Q04771
LQSIPDISTLPWFSL	ATP8B3	171	O60423
RFTNFDLLSLLPPSW	CA13	176	Q8N1Q1
SADNLTLPRWSPAII	CCNY	326	Q8ND76
PSQFRVSPLDRTWNL	CD8A	21	P01732
SPDPSVTLENLLTWQ	ADAM8	261	P78325
RNILSRSTSPWIPQL	CIT	146	O14578
SPTLIQIDRANPWSA	ADAMTS15	391	Q8TE58
WSLPLSQNSASELPA	RAD17	641	O75943
DPDSLRWTPILISNA	KAT6B	981	Q8WYB5
PITRWQDINPALSRS	DUOX1	446	Q9NRD9
ELIASFWPSLPADLQ	MMP27	316	Q9H306
SLSSRPLWNLRSPAE	RPS6KC1	321	Q96S38
FNVSLDSVPELRWLP	NAAA	36	Q02083
TFQSLRPALWTQPLT	HEMK1	76	Q9Y5R4
PNERLTLTWTFSPLE	CFAP65	936	Q6ZU64
NAEASLRRNSPSPWL	JMJD1C	891	Q15652
LFTERWPTTPVNRSL	KIAA1109	3766	Q2LD37
LFLSNPTRDTITPLW	MAPK8IP2	436	Q13387
QAWQLSLPLPSSFLP	PLSCR5	36	A0PG75
SLISCWFSPRPLTQQ	LDAF1	126	Q96B96
LQSPLLPAWRTLSVS	PDE4A	816	P27815
LDNLDSPRSNSWRQP	LMO7	1511	Q8WWI1
FLPEWLTRSPNLNTS	EBPL	146	Q9BY08
QTWLTSPNLDNELPA	OAS2	316	P29728
APPSEVLLTNLWSLS	SLC2A14	76	Q8TDB8
RSWSNIPFITVPLSR	ALDH18A1	41	P54886
AWLDEDSNLSPSPLR	INO80B	121	Q9C086
PASRLDSFVAQWLQP	OASL	11	Q15646
LAQRPVSLLASPWTS	GBA	206	P04062
NPVDLWSAPSSQARL	NPC1	376	O15118
TILDPLDQWQPSSSR	PXN	61	P49023
LSSQTPSLNRDPIWR	PRICKLE2	381	Q7Z3G6
PASPLSWLFLFSAIQ	CPT1C	56	Q8TCG5
SLPNTSPEISRLWSL	DSC3	611	Q14574
TWLIPTLSSPRDQFD	GATAD1	186	Q8WUU5
EFLPDPSALQNLASW	BABAM2	91	Q9NXR7
RSLQRAPSWSFPSNL	DPH7	346	Q9BTV6
SRWIPERISLQAPSN	GABRG3	361	Q99928
LDSTDPRAWLAPTLQ	ATOH1	56	Q92858
TASLLNFWNPPTTAK	CEACAM3	21	P40198
TLSVNWSLLLSPEPD	GLMP	91	Q8WWB7
YTILDPSSQLLRPWT	EPOR	426	P19235
NAPPSEVLLTSLWSL	SLC2A3	51	P11169
LDFSALPSPPWSQQT	C19orf54	36	Q5BKX5
LLPNRPFTTVWNANT	HYAL1	26	Q12794
PRQRPTDQTQWFSIL	ELP5	206	Q8TE02
WAPLSPRLQPLSQSS	GPRIN2	11	O60269
TASLLNFWNPPTTAQ	PSG4	21	Q00888
QWDRLVLNTPSFPSN	RYR1	4701	P21817
SLSLNPFLWSPFESL	CDC27	141	P30260
KASPTQNLFLSPWSI	SERPINB2	21	P05120
SSWRLPQPSFFLVGI	OR52L2P	21	Q8NGH6
LSEIFRNDWLTPAPV	NRK	896	Q7Z2Y5
SLPFPQKLWRLVSSN	HSFX1	96	Q9UBD0
PWTTRLSSNLIPQYA	RSPH4A	606	Q5TD94
QPNLTVSWDPRISSE	SLAMF6	176	Q96DU3
LNTPSSTPWVLDIFL	SPATA31C2	16	B4DYI2
LQEVSNLSEWLSPSP	TOP6BL	561	Q8N6T0
VFRQPLSSLWRSLVP	RSAD2	16	Q8WXG1
SRSETFLLLQPWPRA	TMEM132A	76	Q24JP5
TRSQLSPLEAPALLW	LMF2	626	Q9BU23
LNAPSSTPWVLDIFL	SPATA31A6	16	Q5VVP1
LLASSPAWKQFQRAP	SPATA31A6	881	Q5VVP1
PVWPSLRSDRNNSLE	JAML	366	Q86YT9
TASLLNFWNPPTTAQ	PSG8	21	Q9UQ74
AQWLPSLPTAELRLF	NBEAL2	456	Q6ZNJ1
LNAPSSTPWVLDIFL	SPATA31A7	16	Q8IWB4
NSNPPARLSWTRGSL	SIGLEC8	286	Q9NYZ4
PQSLPAWRSSQRSTQ	XBP1	221	P17861
RPNNSSDLPTSWRGL	PLB1	1111	Q6P1J6
TASLLNFWNPPTTAQ	PSG7	21	Q13046
LNTPSSTPWVLDIFL	SPATA31C1	16	P0DKV0
ASPWRATNPFLNETL	STON2	306	Q8WXE9
LWNLKSPSRPFQTTI	STXBP5L	276	Q9Y2K9
SLLSKPVSSLFQNWP	SHANK1	1931	Q9Y566
NFSLPKNRSWPRINS	CLNK	21	Q7Z7G1
DTFFLITWNSLPPSI	CLCA4	516	Q14CN2
PQILSENWLFSPRSP	C11orf42	286	Q8N5U0
LNAPSSTPWVLDIFL	SPATA31A3	16	Q5VYP0
LGLQSPFLSWLPDNS	TULP2	121	O00295
LNAPSSTPWVLDIFL	SPATA31A1	16	Q5TZJ5
LNAPSSTPWVLDIFL	SPATA31A5	16	Q5VU36
PAWRESQNSLDESLP	RPAP2	421	Q8IXW5
PPGSQRDLNSFLWTI	TRABD2B	31	A6NFA1
SLPPSQTWAQREFFL	TEX52	31	A6NCN8
LWSDPIRTNQLTPYS	UPK3A	181	O75631
PSSVSLWSLEQPFRI	PIK3CD	311	O00329
PSFARTVLWNPEDLI	ZC3H4	971	Q9UPT8
STSVQPWLSPELLRQ	STRADB	226	Q9C0K7
LPYLPSNWANTASSL	SYCN	66	Q0VAF6
SVPQSLPSLAVRDWL	TRIM8	511	Q9BZR9
WRLISNFLFSNPPPT	UBXN4	426	Q92575
PLQPVTQNRASRSSW	PKP2	276	Q99959
NSWPSSLQELLRPTF	UGGT1	471	Q9NYU2
QSPLFTLNLNTPESW	UGGT1	1066	Q9NYU2
LDLPNRPETSFLWFT	MYOF	1996	Q9NZM1